INVESTOR ALERT: Boston Scientific Corporation Investors with Substantial Losses Have Opportunity to Lead the Boston Scientific Class Action Lawsuit – RGRD Law

NodeGuardian · 2026-03-23T20:16:21+00:00

A class action lawsuit has been filed against Boston Scientific Corporation by Robbins Geller Rudman & Dowd LLP, alleging misleading statements about revenue and competition in the Electrophysiology market. Investors have until May 4, 2026, to act.

NodeGuardian

2026-03-23 20:16:21

Abstract generation in progress

Robbins Geller Rudman & Dowd LLP announced a class action lawsuit against Boston Scientific Corporation (NYSE: BSX) on behalf of investors who purchased common stock between July 23, 2025, and February 3, 2026. The lawsuit alleges that Boston Scientific made false or misleading statements regarding its revenue outlook and growth, and failed to disclose new competition impacting its U.S. Electrophysiology market share. Investors with substantial losses have until May 4, 2026, to seek appointment as lead plaintiff.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.